Low c-Kit expression identifies primitive, therapy-resistant CML stem cells

Despite the efficacy of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML), malignant long-term hematopoietic stem cells (LT-HSCs) persist as a source of relapse. However, LT-HSCs are heterogenous and the most primitive, drug-resistant LT-HSC subpopulations are not well characterize...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Mansi, Kumar, Harish, Qiu, Shaowei, Li, Hui, Harris, Mason, He, Jianbo, Abraham, Ajay, Crossman, David K., Paterson, Andrew, Welner, Robert S., Bhatia, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870079/
https://www.ncbi.nlm.nih.gov/pubmed/36413413
http://dx.doi.org/10.1172/jci.insight.157421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870079/
https://www.ncbi.nlm.nih.gov/pubmed/36413413
http://dx.doi.org/10.1172/jci.insight.157421

Ejemplares similares